SFSIG
IBB icon

San Francisco Sentry Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$11K Sell
70
-600
-90% -$92.4K 0.01% 510
2021
Q1 		$101K Hold
670
– – 0.04% 297
2020
Q4 		$101K Sell
670
-4,220
-86% -$603K 0.05% 275
2020
Q3 		$662K Sell
4,890
-90
-2% -$12.2K 0.34% 79
2020
Q2 		$681K Sell
4,980
-85
-2% -$10.8K 0.36% 71
2020
Q1 		$546K Buy
5,065
+220
+5% +$25.3K 0.35% 75
2019
Q4 		$584K Buy
4,845
+155
+3% +$17.3K 0.26% 98
2019
Q3 		$467K Buy
4,690
+250
+6% +$26.2K 0.21% 110
2019
Q2 		$484K Buy
4,440
+2,550
+135% +$271K 0.22% 109
2019
Q1 		$211K Sell
1,890
-120
-6% -$13.2K 0.09% 205
2018
Q4 		$194K Hold
2,010
– – 0.09% 192
2018
Q3 		$245K Sell
2,010
-300
-13% -$35.3K 0.09% 179
2018
Q2 		$254K Sell
2,310
-9,973
-81% -$1.07M 0.11% 172
2018
Q1 		$1.31M Sell
12,283
-45
-0.4% -$4.99K 0.38% 53
2017
Q4 		$1.32M Sell
12,328
-2,381
-16% -$255K 0.39% 53
2017
Q3 		$1.64M Buy
14,709
+135
+0.9% +$14.4K 0.55% 41
2017
Q2 		$1.51M Buy
14,574
+624
+4% +$61.5K 0.54% 36
2017
Q1 		$1.36M Sell
13,950
-1,515
-10% -$145K 0.75% 36
2016
Q4 		$1.37M Sell
15,465
-270
-2% -$24.6K 0.79% 35
2016
Q3 		$1.52M Sell
15,735
-1,695
-10% -$161K 0.9% 34
2016
Q2 		$1.5M Buy
17,430
+1,140
+7% +$102K 0.92% 33
2016
Q1 		$1.42M Buy
16,290
+1,125
+7% +$101K 0.85% 32
2015
Q4 		$1.71M Buy
15,165
+1,116
+8% +$121K 1.07% 24
2015
Q3 		$1.42M Sell
14,049
-210
-1% -$25.2K 1% 26
2015
Q2 		$1.75M Sell
14,259
-555
-4% -$66.4K 1.05% 20
2015
Q1 		$1.7M Sell
14,814
-3,015
-17% -$333K 1.01% 20
2014
Q4 		$1.8M Sell
17,829
-30
-0.2% -$2.92K 1.04% 21
2014
Q3 		$1.63M Sell
17,859
-420
-2% -$36.9K 0.82% 27
2014
Q2 		$1.57M Buy
18,279
+780
+4% +$61.5K 0.75% 29
2014
Q1 		$1.38M Buy
17,499
+570
+3% +$47.5K 0.44% 55
2013
Q4 		$1.28M Buy
16,929
+750
+5% +$53.2K 0.44% 54
2013
Q3 		$1.13M Buy
16,179
+300
+2% +$19.7K 0.43% 61
2013
Q2 		$920K Buy
+15,879
New +$918K 0.33% 75

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

San Francisco Sentry Investment Group's IBB Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its iShares Biotechnology ETF (IBB) stake by 90% in Q2 2021, selling an estimated $92.4K and leaving 70 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #510.

San Francisco Sentry Investment Group first reported a position in IBB in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.8M in Q4 2014. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • San Francisco Sentry Investment Group held 70 shares of iShares Biotechnology ETF worth $11K as of Q2 2021.
  • San Francisco Sentry Investment Group sold 600 iShares Biotechnology ETF shares in Q2 2021, an estimated $92.4K.
  • iShares Biotechnology ETF made up 0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #510 holding.
  • San Francisco Sentry Investment Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 33 quarters since.
  • San Francisco Sentry Investment Group's iShares Biotechnology ETF position peaked at $1.8M in Q4 2014.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.